Characterization of murine macrophages from bone marrow, spleen and peritoneum

BMC Immunology

David CH Harris¹  Yiping Wang¹  Ye Zhao¹  Hong Zhao³  Thian Kui Tan¹  Guoping Zheng¹  Ya Wang¹  Qi Cao¹  Xiao Yu²  Changqi Wang¹ 

[1] Centre for Transplant and Renal Research at Westmead, Sydney, NSW, Australia;Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, PR China;Department of Biochemistry and Molecular Biology, Shanxi Medical University, Shanxi, PR China

关键词: Peritoneum;    Spleen;    Bone marrow;    Macrophage;   

Others  :  1077841
DOI  :  10.1186/1471-2172-14-6

 received in 2012-09-04, accepted in 2013-01-25,  发布年份 2013

【 摘 要 】

Background

Macrophages have heterogeneous phenotypes and complex functions within both innate and adaptive immune responses. To date, most experimental studies have been performed on macrophages derived from bone marrow, spleen and peritoneum. However, differences among macrophages from these particular sources remain unclear. In this study, the features of murine macrophages from bone marrow, spleen and peritoneum were compared.

Results

We found that peritoneal macrophages (PMs) appear to be more mature than bone marrow derived macrophages (BMs) and splenic macrophages (SPMs) based on their morphology and surface molecular characteristics. BMs showed the strongest capacity for both proliferation and phagocytosis among the three populations of macrophage. Under resting conditions, SPMs maintained high levels of pro-inflammatory cytokines expression (IL-6, IL-12 and TNF-α), whereas BMs produced high levels of suppressive cytokines (IL-10 and TGF-β). However, SPMs activated with LPS not only maintained higher levels of (IL-6, IL-12 and TNF-α) than BMs or PMs, but also maintained higher levels of IL-10 and TGF-β.

Conclusions

Our results show that BMs, SPMs and PMs are distinct populations with different biological functions, providing clues to guide their further experimental or therapeutic use.

【 授权许可】

   
2013 Wang et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 4.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

【 参考文献 】

• [1]Gordon S: The macrophage: past, present and future. Eur J Immunol 2007, 37(Suppl 1):S9-S17.
• [2]Sasmono RT, Oceandy D, Pollard JW, Tong W, Pavli P, Wainwright BJ, Ostrowski MC, Himes SR, Hume DA: A macrophage colony-stimulating factor receptor-green fluorescent protein transgene is expressed throughout the mononuclear phagocyte system of the mouse. Blood 2003, 101:1155-1163.
• [3]Hume DA, Ross IL, Himes SR, Sasmono RT, Wells CA, Ravasi T: The mononuclear phagocyte system revisited. J Leukoc Biol 2002, 72:621-627.
• [4]Shortman K, Wu L: Are dendritic cells end cells? Nat Immunol 2004, 5:1105-1106.
• [5]Rous P: The Relative Reaction within Living Mammalian-Tissues: Ii. On the Mobilization of Acid Material within Cells, and the Reaction as Influenced by the Cell State. J Exp Med 1925, 41:399-411.
• [6]Kaufmann SH, Schaible UE: Antigen presentation and recognition in bacterial infections. Curr Opin Immunol 2005, 17:79-87.
• [7]Liu G, Xia XP, Gong SL, Zhao Y: The macrophage heterogeneity: difference between mouse peritoneal exudate and splenic F4/80+ macrophages. J Cell Physiol 2006, 209:341-352.
• [8]Zhu YN, Yang YF, Ono S, Zhong XG, Feng YH, Ren YX, Ni J, Fu YF, Tang W, Zuo JP: Differential expression of inducible nitric oxide synthase and IL-12 between peritoneal and splenic macrophages stimulated with LPS plus IFN-gamma is associated with the activation of extracellular signal-related kinase. Int Immunol 2006, 18:981-990.
• [9]Springer T, Galfre G, Secher DS, Milstein C: Mac-1: a macrophage differentiation antigen identified by monoclonal antibody. Eur J Immunol 1979, 9:301-306.
• [10]Austyn JM, Gordon S: F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur J Immunol 1981, 11:805-815.
• [11]Hume DA, Robinson AP, MacPherson GG, Gordon S: The mononuclear phagocyte system of the mouse defined by immunohistochemical localization of antigen F4/80. Relationship between macrophages, Langerhans cells, reticular cells, and dendritic cells in lymphoid and hematopoietic organs. J Exp Med 1983, 158:1522-1536.
• [12]Kraal G, Rep M, Janse M: Macrophages in T and B cell compartments and other tissue macrophages recognized by monoclonal antibody MOMA-2.An immunohistochemical study. Scand J Immunol 1987, 26:653-661.
• [13]Lane TE, Wu-Hsieh BA, Howard DH: Gamma interferon cooperates with lipopolysaccharide to activate mouse splenic macrophages to an antihistoplasma state. Infect Immun 1993, 61:1468-1473.
• [14]Kim JG, Keshava C, Murphy AA, Pitas RE, Parthasarathy S: Fresh mouse peritoneal macrophages have low scavenger receptor activity. J Lipid Res 1997, 38:2207-2215.
• [15]Yang X, Ye RG, Kong QY, Yang QQ, Gao Y, Zhong JH, Wang T: CD40 ligand expression on macrophages during peritonitis in continuous ambulatory peritoneal dialysis patients. Adv Perit Dial 2000, 16:213-215.
• [16]Gordon S: Pathogen recognition or homeostasis? APC receptor functions in innate immunity. C R Biol 2004, 327:603-607.
• [17]Wang Y, Harris DC: Macrophages in renal disease. J Am Soc Nephrol 2011, 22:21-27.
• [18]Hume DA, Gordon S: Regulation of bone-marrow macrophage proliferation. Adv Exp Med Biol 1982, 155:261-266.
• [19]Gordon S: The role of the macrophage in immune regulation. Res Immunol 1998, 149:685-688.
• [20]Goodrum KJ: Complement component C3 secretion by mouse macrophage-like cell lines. J Leukoc Biol 1987, 41:295-301.
• [21]Baek YS, Haas S, Hackstein H, Bein G, Hernandez-Santana M, Lehrach H, Sauer S, Seitz H: Identification of novel transcriptional regulators involved in macrophage differentiation and activation in U937 cells. BMC Immunol 2009, 10:18. BioMed Central Full Text
• [22]Wells CA, Ravasi T, Faulkner GJ, Carninci P, Okazaki Y, Hayashizaki Y, Sweet M, Wainwright BJ, Hume DA: Genetic control of the innate immune response. BMC Immunol 2003, 4:5. BioMed Central Full Text
• [23]Weischenfeldt J, Porse B: Bone Marrow-Derived Macrophages (BMM): Isolation and Applications. CSH Protoc 2008, 2008:pdb prot5080.
• [24]Marim FM, Silveira TN, Lima DS Jr, Zamboni DS: A method for generation of bone marrow-derived macrophages from cryopreserved mouse bone marrow cells. PLoS One 2010, 5:e15263.
• [25]Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, Ley K: Development of monocytes, macrophages, and dendritic cells. Science 2010, 327:656-661.
• [26]Alatery A, Basta S: An efficient culture method for generating large quantities of mature mouse splenic macrophages. J Immunol Methods 2008, 338:47-57.
• [27]Andreesen R, Brugger W, Scheibenbogen C, Kreutz M, Leser HG, Rehm A, Lohr GW: Surface phenotype analysis of human monocyte to macrophage maturation. J Leukoc Biol 1990, 47:490-497.
• [28]Wang Y, Cui X, Tai G, Ge J, Li N, Chen F, Yu F, Liu Z: A critical role of activin A in maturation of mouse peritoneal macrophages in vitro and in vivo. Cell Mol Immunol 2009, 6:387-392.
• [29]Huang B, Pan PY, Li Q, Sato AI, Levy DE, Bromberg J, Divino CM, Chen SH: Gr-1 + CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Res 2006, 66:1123-1131.
• [30]Arnold L, Henry A, Poron F, Baba-Amer Y, van Rooijen N, Plonquet A, Gherardi RK, Chazaud B: Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J Exp Med 2007, 204:1057-1069.
• [31]Brown BN, Ratner BD, Goodman SB, Amar S, Badylak SF: Macrophage polarization: an opportunity for improved outcomes in biomaterials and regenerative medicine. Biomaterials 2012, 33:3792-3802.
• [32]Nelson PJ, Rees AJ, Griffin MD, Hughes J, Kurts C, Duffield J: The renal mononuclear phagocytic system. J Am Soc Nephrol 2012, 23:194-203.
• [33]Ruffell D, Mourkioti F, Gambardella A, Kirstetter P, Lopez RG, Rosenthal N, Nerlov C: A CREB-C/EBPbeta cascade induces M2 macrophage-specific gene expression and promotes muscle injury repair. Proc Natl Acad Sci U S A 2009, 106:17475-17480.
• [34]Wang Y, Cao Q, Zheng G, Lee VW, Zheng D, Li X, Tan TK, Harris DC: By homing to the kidney, activated macrophages potently exacerbate renal injury. Am J Pathol 2008, 172:1491-1499.
• [35]Cao Q, Zheng D, Sun Y, Wang Y, Lee VW, Zheng G, Alexander SI, Harris DC: Impaired alternative activated macrophages from bone marrow in treatment of CKD: Associations with their proliferation in inflamed kidney. Presented in abstract form at the annual meeting of the American Society of Nephrology; October 27 through November 1, 2009. CA: San Diego;
• [36]Cao Q, Wang C, Zheng D, Wang Y, Lee VW, Wang YM, Zheng G, Tan TK, Yu D, Alexander SI, Harris DC: IL-25 Induces M2 Macrophages and Reduces Renal Injury in Proteinuric Kidney Disease. J Am Soc Nephrol 2011, 22:1229-1239.
• [37]Zheng D, Wang Y, Cao Q, Lee VW, Zheng G, Sun Y, Tan TK, Alexander SI, Harris DC: Transfused macrophages ameliorate pancreatic and renal injury in murine diabetes mellitus. Nephron Exp Nephrol 2011, 118:e87-99.
• [38]Mitchison NA: The immunogenic capacity of antigen taken up by peritoneal exudate cells. Immunology 1969, 16:1-14.
• [39]Cannon GJ, Swanson JA: The macrophage capacity for phagocytosis. J Cell Sci 1992, 101(Pt 4):907-913.
• [40]Zhou X, Nicoletti A, Elhage R, Hansson GK: Transfer of CD4(+) T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice. Circulation 2000, 102:2919-2922.
• [41]Isomaki P, Clark JM, Panesar M, Cope AP: Pathways of T cell activation and terminal differentiation in chronic inflammation. Curr Drug Targets Inflamm Allergy 2005, 4:287-293.
• [42]Petroff MG, Kharatyan E, Torry DS, Holets L: The immunomodulatory proteins B7-DC, B7-H2, and B7-H3 are differentially expressed across gestation in the human placenta. Am J Pathol 2005, 167:465-473.
• [43]Anderson CF, Mosser DM: A novel phenotype for an activated macrophage: the type 2 activated macrophage. J Leukoc Biol 2002, 72:101-106.
• [44]Millard AL, Mertes PM, Ittelet D, Villard F, Jeannesson P, Bernard J: Butyrate affects differentiation, maturation and function of human monocyte-derived dendritic cells and macrophages. Clin Exp Immunol 2002, 130:245-255.
• [45]Warren MK, Vogel SN: Bone marrow-derived macrophages: development and regulation of differentiation markers by colony-stimulating factor and interferons. J Immunol 1985, 134:982-989.
• [46]Xu W, Schlagwein N, Roos A, van den Berg TK, Daha MR, van Kooten C: Human peritoneal macrophages show functional characteristics of M-CSF-driven anti-inflammatory type 2 macrophages. Eur J Immunol 2007, 37:1594-1599.
• [47]Gately MK, Wolitzky AG, Quinn PM, Chizzonite R: Regulation of human cytolytic lymphocyte responses by interleukin-12. Cell Immunol 1992, 143:127-142.
• [48]Galligioni E, Favaro D, Santarosa M, Quaia M, Spada A, Freschi A, Alberti D: Induction and maintenance of monocyte cytotoxicity during treatment with liposomes containing muramyl tripeptide despite tachyphylaxis to the cytokine response. Clin Cancer Res 1995, 1:493-499.